Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases Bo Deng, MD, PhD, Stephen D. Cassivi, MD, Mariza.

Slides:

Advertisements

Similar presentations

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Advertisements

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Stephen R. Broderick, MD, MPHS

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

Quantification of emphysema with preoperative computed tomography has stronger association with pulmonary complications than pulmonary function test results.

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Antonio L Visbal, MD, Brent.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months Arturo Navarro-Martin, MD, Samantha Aso, MD, Jon Cacicedo,

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Trends in Subpopulations at High Risk for Lung Cancer

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Outcomes of surgery for young children with multivessel pulmonary vein stenosis Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina.

Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases Toshihiko Sato, MD,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

K. Robert Shen, MD, Mark S. Allen, MD, Stephen D

A Randomized Controlled Trial of Bupivacaine Through Intracostal Catheters for Pain Management After Thoracotomy Mark S. Allen, MD, Lisa Halgren, RN,

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Victor van Berkel, MD, PhD

Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients Jie Dai, PhD,

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Theolyn N. Price, MD, Mark S. Allen, MD, Francis C

Surgical Resection of Rare Esophageal Cancers

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Sporadic Obliterative Bronchiolitis: Case Series and Systematic Review of the Literature Sean J. Callahan, MD, Andrew Vranic, MD, Lucia Flors, MD, Michael.

Ping Yang, MD, PhD, Kimary Kulig, PhD, MPH, Jennifer M

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Karen M. Harrison–Phipps, MD, Francis C. Nichols, MD, Cathy D

Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base Kathryn E. Engelhardt,

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

John Agzarian, MD, MPH, Sue L. Visscher, PhD, Ariel W

Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.

Lobar torsion after pulmonary resection: Presentation and outcome

Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non–small cell.

Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients.

Survival After Surgical Resection of Stage IV Esophageal Cancer

Variation in Hospital Adoption Rates of Video-Assisted Thoracoscopic Lobectomy for Lung Cancer and the Effect on Outcomes Zaid M. Abdelsattar, MD, MS,

A first start for lung transplantation?

Preoperative pulmonary function tests predict mortality after surgical or transcatheter aortic valve replacement Matthew C. Henn, MD, Alan Zajarias,

Stephen R. Broderick, MD, MPHS

Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer Hiroaki Nomori, MD, Atsushi Shiraishi, MD, Yue Cong, MD,

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Bullectomy for Symptomatic or Complicated Giant Lung Bullae

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Raja M. Flores, MD, Bernard J

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Aritoshi Hattori, MD, Kenji Suzuki, MD

Energized lung resections

Preoperative PFTs: The answer is blowing in the wind

Ping Yang, MD, PhD, Andrea L. Cheville, MD, Jason A

Is pulmonary function damaged by neoadjuvant lung cancer therapy

Presentation transcript:

Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases Bo Deng, MD, PhD, Stephen D. Cassivi, MD, Mariza de Andrade, PhD, Francis C. Nichols, MD, Victor F. Trastek, MD, Yi Wang, MD, MS, Jason A. Wampfler, BS, Shawn M. Stoddard, RN, Dennis A. Wigle, MD, PhD, Robert K. Shen, MD, Mark S. Allen, MD, Claude Deschamps, MD, Ping Yang, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 4, Pages 1186-1192.e3 (October 2014) DOI: 10.1016/j.jtcvs.2014.03.019 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Proportion of surgery types of 2509 cases, 1997 to 2012, Mayo Clinic (Minnesota). VATS, Video-assisted thoracic surgery. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1186-1192.e3DOI: (10.1016/j.jtcvs.2014.03.019) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 No significant difference was found in the trend of postoperative pulmonary function test (PFT) data. A, Forced expiratory volume in 1 second (FEV1), (B) forced vital capacity (FVC), and (C) diffusing capacity of the lung for carbon monoxide (DLCO) after segmentectomy or lobectomy. LS, Least squares. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1186-1192.e3DOI: (10.1016/j.jtcvs.2014.03.019) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Overall and disease-free survival of patients with stage T1a and T1b after segmentectomy or lobectomy. No significant difference was found in overall or disease-free survival for those with T1a after (A) segmentectomy or (B) lobectomy. A marginally significant difference was found in overall and disease-free survival for those with stage T1b after (C) segmentectomy or (D) lobectomy. CI, Confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1186-1192.e3DOI: (10.1016/j.jtcvs.2014.03.019) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions